scispace - formally typeset
R

Rajamani Lakshminarayanan

Researcher at National University of Singapore

Publications -  160
Citations -  6561

Rajamani Lakshminarayanan is an academic researcher from National University of Singapore. The author has contributed to research in topics: Antimicrobial & Amelogenin. The author has an hindex of 40, co-authored 140 publications receiving 5005 citations. Previous affiliations of Rajamani Lakshminarayanan include Nanyang Technological University & University of Southern California.

Papers
More filters
Journal ArticleDOI

Methods and strategies for the synthesis of diverse nanoparticles and their applications: a comprehensive overview

TL;DR: A comprehensive overview on various physical, chemical and bio-assisted methods largely employed to synthesize and fabricate NPs of varying size, surface characteristics, functionalities and physicochemical behavior is provided in this paper.
Journal ArticleDOI

Electrosprayed nanoparticles and electrospun nanofibers based on natural materials: applications in tissue regeneration, drug delivery and pharmaceuticals

TL;DR: This review focuses on the nanoformulation of natural materials via the electrospraying or electrospinning of nanoparticles or nanofibers for tissue engineering or drug delivery/pharmaceutical purposes and classify the natural materials with respect to their animal/plant origin and macrocyclic, small molecule or herbal active constituents.
Journal ArticleDOI

Membrane Active Antimicrobial Peptides: Translating Mechanistic Insights to Design.

TL;DR: Technological developments are now enabling multidisciplinary approaches including molecular dynamics simulations combined with biophysics and microbiology toward providing valuable insights into the interactions of AMPs with membranes at atomic level, and has begun to contribute meaningfully toward the discovery of new AMPs.
Journal ArticleDOI

Recent Advances of Using Hybrid Nanocarriers in Remotely Controlled Therapeutic Delivery

TL;DR: The recent advances in using hybrid nanovehicles as remotely controlled therapeutic delivery carriers are summarized with respect to different nanostructures, including hybrid host-guest nanoconjugates, micelles, nanogels, core-shell nanoparticles, liposomes, mesoporous silica, and hollow nanoconstructions.